about
HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBECChimpanzee reservoirs of pandemic and nonpandemic HIV-1Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpzOrigin of HIV-1 in the chimpanzee Pan troglodytes troglodytesSimian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2.Origin of the human malaria parasite Plasmodium falciparum in gorillasPolyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsHIV-Host Interactions: Implications for Vaccine DesignMulti-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque ControllersStructure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding siteHuman Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus MacaquesMaturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic AntibodyCo-evolution of a broadly neutralizing HIV-1 antibody and founder virusCombinatorial Optimization of a CD4-Mimetic Miniprotein and Cocrystal Structures with HIV-1 gp120 Envelope GlycoproteinHuman immunodeficiency viruses: SIV infection in wild gorillasMolecular ecology and natural history of simian foamy virus infection in wild-living chimpanzeesElucidation of hepatitis C virus transmission and early diversification by single genome sequencingCross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapyAutologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysMultigenomic Delineation of Plasmodium Species of the Laverania Subgenus Infecting Wild-Living Chimpanzees and Gorillas.Antibody neutralization and escape by HIV-1Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzeeOrigin of AIDS: contaminated polio vaccine theory refuted.Adaptation of HIV-1 to its human host.Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria.African origin of the malaria parasite Plasmodium vivaxEastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir.High prevalence of simian immunodeficiency virus infection in a community of savanna chimpanzeesPlasmodium falciparum-like parasites infecting wild apes in southern Cameroon do not represent a recurrent source of human malariaB cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1Effective treatment of SIVcpz-induced immunodeficiency in a captive western chimpanzeePolyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infectionEscape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearanceA rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing.
P50
Q21559422-069C0AA8-7116-4537-A835-929D3C9CF847Q22242279-B744AB79-303D-4F84-91B3-5B172C6A78F0Q22251087-59A9BFEE-DA53-4820-B820-5314A4F2027DQ22251299-94CBA0D7-B9C1-4D81-9422-D0212C6DE346Q24533334-A66A2DA2-B72F-49CB-AD37-DA9735F2182DQ24631176-B86F9D88-28D2-4F75-BD42-A904806EC056Q24635002-B4A6DB50-CFB7-4D65-BF21-6A0E15E91F73Q26765966-7233F8FA-6232-46A6-9384-582C24907A73Q27312050-E60A2FD4-D107-4285-9DD1-4CA72C778CEDQ27316899-2FA60712-D34A-4CA0-8B96-B151B5B6C246Q27318508-831B9A23-E5BD-4626-BADB-3D2D2FD7E29DQ27644415-FCEEE935-BC28-4C26-9E15-009B01F30DA2Q27644501-860963D1-5F67-4226-B0C4-B7452052D617Q27651139-10F9FAD6-AC44-4B2F-B121-7B4073F20DFEQ28273219-E00AA4B4-A2C6-4D70-A9DF-87F5CBD54BD9Q28286256-59C7B253-AC86-42D7-A32F-28D6C5F39FE0Q28482493-B9227C8F-1C6A-4FB9-9BAE-98F0C7BA2D2FQ28740329-8B387797-2CF7-493E-98E0-B0DE1EA0AE3BQ28751926-3DF75BD4-E983-470A-ABCE-CA2A20A8CED9Q28830288-CCAD556B-F438-4C4B-AC10-639FB2FF8EEAQ29547345-93814423-BED0-4C71-9A25-5367C1B1A42BQ29619254-F5B7D8A2-4510-4BB2-9699-ECA9923770DBQ30332406-BBBDDDA8-09B1-4A8F-AEDE-7198CAB7E332Q30341339-3FDD2879-F5E0-4E37-86B9-F9FA173C60F8Q30362085-1D8A071F-1C7E-4256-ADD7-EC49CA0455C4Q30382590-58919188-81D2-445E-BFDC-BA7B38DE4F11Q30385381-DCCD06AD-152A-4D1F-A3A1-0AD6CA90950EQ30391284-28522E81-3312-46C5-86A5-D7D31B646656Q30419742-A5049D74-D1FD-48AD-A7D9-FC15DA66DE38Q30469085-AD0DD2C1-9D80-4D17-ABE5-182303A9B9BAQ31075031-590AC28D-6ACC-4B35-9E6D-C5BF6B28D0A7Q33373664-F408F4F8-8361-4362-AB83-C4378CB062F8Q33402461-5567001E-4725-4C1E-A9FA-3D15D42B05A6Q33442370-D24A6C7A-982E-4DD8-9FDD-9DDB31A54F66Q33479167-69D9863E-AECF-4C79-92EF-EA58FE6B8CD5Q33504599-0ABEC9FB-1CAE-49BE-B5B6-C21AA58E83F3Q33582135-6377C2FE-3A14-4336-A5A1-15333BC7D4C2Q33631104-D36970CC-B8B8-4406-9519-BA1A3C6432A4Q33653774-AD7A3FA9-CD60-48A6-9772-0B20FAED3967Q33680395-AF2CB3F1-118B-44B6-B071-C9B0B6C97D8D
P50
description
virologist
@en
name
George M. Shaw
@en
George M. Shaw
@nl
type
label
George M. Shaw
@en
George M. Shaw
@nl
prefLabel
George M. Shaw
@en
George M. Shaw
@nl